Zimmer Biomet Holdings ZBH EMEA — D&A
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zimmer Biomet Holdings in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zimmer Biomet Holdings's emea — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zimmer Biomet Holdings's EMEA — D&A?
- Zimmer Biomet Holdings (ZBH) reported EMEA — D&A of $16.5M in Q1 2026.
- How has Zimmer Biomet Holdings's EMEA — D&A changed year-over-year?
- Zimmer Biomet Holdings's EMEA — D&A increased by 5.8% year-over-year, from $15.6M to $16.5M.
- What is the long-term trend for Zimmer Biomet Holdings's EMEA — D&A?
- Over 4 years (2021 to 2025), Zimmer Biomet Holdings's EMEA — D&A has grown at a -1.9% compound annual growth rate (CAGR), from $71.4M to $66.2M.
- What does EMEA — D&A mean?
- This metric represents the non-cash expense allocated to the EMEA segment for the systematic reduction in the value of tangible fixed assets and intangible assets over their useful lives. It reflects the consumption of capital investments in regional manufacturing, distribution, and surgical equipment infrastructure. Monitoring this helps investors understand the capital intensity required to maintain the segment's operational capacity.